Skip to main content
Erschienen in: Tumor Biology 5/2015

01.05.2015 | Research Article

MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2

verfasst von: Ping Huang, Bo Ye, Yu Yang, Jianxin Shi, Heng Zhao

Erschienen in: Tumor Biology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs frequently dysregulated in human malignancies. In this study, we analyzed the global expression profile of miR-181 in non-small cell lung cancer (NSCLC), as its participation in some other types of cancer has been suggested by previous reports. We found that miR-181 was downregulated both in NSCLC tissues and cell lines. Overexpression of miR-181evidently inhibited A549 cell proliferation, migration, and invasion and promotes cell apoptosis. Moreover, we also found miR-181 reduction was associated with increased Bcl-2 levels and miR-181 was further suggested to exert its pro-apoptotic function mainly through targeting Bcl-2 expression. Taken together, our study implicates important roles of miR-181 in lung cancer pathogenesis and implicates its potential application in cancer therapy.
Literatur
1.
2.
Zurück zum Zitat Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6:449–58.CrossRefPubMed Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6:449–58.CrossRefPubMed
3.
Zurück zum Zitat Van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res. 2012;110:496–507.CrossRefPubMed Van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res. 2012;110:496–507.CrossRefPubMed
4.
Zurück zum Zitat Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25:6163–9.CrossRefPubMed Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25:6163–9.CrossRefPubMed
5.
6.
Zurück zum Zitat Chitwood DH, Timmermans MC. Small RNAs are on the move. Nature. 2010;67:415–9.CrossRef Chitwood DH, Timmermans MC. Small RNAs are on the move. Nature. 2010;67:415–9.CrossRef
7.
8.
9.
10.
Zurück zum Zitat Ryan DG, Oliveira-Fernandes M, Lavker RM. Micro-RNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis. 2006;12:1175–84.PubMed Ryan DG, Oliveira-Fernandes M, Lavker RM. Micro-RNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis. 2006;12:1175–84.PubMed
11.
Zurück zum Zitat Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M, et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol. 2006;8:278–84.CrossRefPubMed Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M, et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol. 2006;8:278–84.CrossRefPubMed
12.
Zurück zum Zitat Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–6.CrossRefPubMed Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–6.CrossRefPubMed
13.
Zurück zum Zitat Georgantas III RW, Hildreth R, Morisot S, Alder J, Liu C, Heimfeld S, et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007;104:2750–5.CrossRefPubMedPubMedCentral Georgantas III RW, Hildreth R, Morisot S, Alder J, Liu C, Heimfeld S, et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007;104:2750–5.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ji J, Yamashita T, Budhu A, Jia H, Li C, Deng C, et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology. 2009;50:472–80.CrossRefPubMedPubMedCentral Ji J, Yamashita T, Budhu A, Jia H, Li C, Deng C, et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology. 2009;50:472–80.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, et al. Hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008;1236:185–93.CrossRefPubMed Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, et al. Hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008;1236:185–93.CrossRefPubMed
16.
Zurück zum Zitat Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol. 2007;210:370–7.CrossRefPubMed Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol. 2007;210:370–7.CrossRefPubMed
17.
Zurück zum Zitat Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, et al. Karyotype specific microRNA signature in chronic lymphocytic leukemia. Blood. 2009;144:3872–9.CrossRef Visone R, Rassenti LZ, Veronese A, Taccioli C, Costinean S, Aguda BD, et al. Karyotype specific microRNA signature in chronic lymphocytic leukemia. Blood. 2009;144:3872–9.CrossRef
18.
Zurück zum Zitat Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, et al. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother. 2010;64:399–408.CrossRefPubMed Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, et al. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother. 2010;64:399–408.CrossRefPubMed
19.
Zurück zum Zitat Zhu W, Shan X, Wang T, Shu YQ, Liu P. MiR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer. 2010. doi:10.1002/ijc.25260. Zhu W, Shan X, Wang T, Shu YQ, Liu P. MiR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer. 2010. doi:10.​1002/​ijc.​25260.
20.
Zurück zum Zitat Su H, Yang J, Xu T, Huang J, Xu L, Yuan Y, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009;69:1135–42.CrossRefPubMed Su H, Yang J, Xu T, Huang J, Xu L, Yuan Y, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009;69:1135–42.CrossRefPubMed
21.
Zurück zum Zitat Bhatavdekar JM, Patel DD, Ghosh N, Chikhlikar PR, Trivedi TI, Suthar TP, et al. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Dis Colon Rectum. 1997;40:785–90.CrossRefPubMed Bhatavdekar JM, Patel DD, Ghosh N, Chikhlikar PR, Trivedi TI, Suthar TP, et al. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma. Dis Colon Rectum. 1997;40:785–90.CrossRefPubMed
22.
Zurück zum Zitat Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, Hickman JA. Differential expression of Bcl-2 in intestinal epithelia correlation with ttenuationof apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci. 1995;108:2261–71.PubMed Merritt AJ, Potten CS, Watson AJ, Loh DY, Nakayama K, Hickman JA. Differential expression of Bcl-2 in intestinal epithelia correlation with ttenuationof apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci. 1995;108:2261–71.PubMed
23.
Zurück zum Zitat Hummel R, Hussey DJ, Haier J. MicroRNAs predictors and modifiers of chemo-and radiotherapy in different tumor types. Eur J Cancer. 2010;46:298–311.CrossRefPubMed Hummel R, Hussey DJ, Haier J. MicroRNAs predictors and modifiers of chemo-and radiotherapy in different tumor types. Eur J Cancer. 2010;46:298–311.CrossRefPubMed
24.
Zurück zum Zitat Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. Micro-RNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci. 2006;103:2257–61.CrossRefPubMedPubMedCentral Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. Micro-RNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci. 2006;103:2257–61.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Mishra PJ, Merlino G. MicroRNA reexpression as differentiation therapy in cancer. J Clin Invest. 2009;119:2119–23.PubMedPubMedCentral Mishra PJ, Merlino G. MicroRNA reexpression as differentiation therapy in cancer. J Clin Invest. 2009;119:2119–23.PubMedPubMedCentral
Metadaten
Titel
MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2
verfasst von
Ping Huang
Bo Ye
Yu Yang
Jianxin Shi
Heng Zhao
Publikationsdatum
01.05.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 5/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2972-z

Weitere Artikel der Ausgabe 5/2015

Tumor Biology 5/2015 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.